O. Gilliot

435 total citations
11 papers, 247 citations indexed

About

O. Gilliot is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, O. Gilliot has authored 11 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in O. Gilliot's work include Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Risks and Factors (2 papers). O. Gilliot is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Risks and Factors (2 papers). O. Gilliot collaborates with scholars based in France. O. Gilliot's co-authors include Philippe Bergerot, Yazid Belkacémi, Pierre Baumann, Nicolas Magné, D. Azria, Dominique Pasquier, Pierre Richaud, Meryem Brihoum, Paul Sargos and Sylvie Chabaud and has published in prestigious journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Acta Dermato Venereologica.

In The Last Decade

O. Gilliot

9 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Gilliot France 5 180 57 48 46 34 11 247
Bruce Hershatter United States 7 191 1.1× 50 0.9× 33 0.7× 70 1.5× 39 1.1× 29 270
Sara Khaksar United Kingdom 9 189 1.1× 67 1.2× 39 0.8× 33 0.7× 24 0.7× 22 230
Shaun Tolan United Kingdom 10 184 1.0× 53 0.9× 109 2.3× 56 1.2× 37 1.1× 15 283
Hiral P. Fontanilla United States 9 161 0.9× 47 0.8× 46 1.0× 90 2.0× 25 0.7× 15 289
Moses Arunsingh India 11 136 0.8× 89 1.6× 44 0.9× 64 1.4× 51 1.5× 42 228
O. Hernando Spain 8 63 0.3× 58 1.0× 48 1.0× 53 1.2× 42 1.2× 36 196
Pervin Hürmüz Türkiye 12 239 1.3× 89 1.6× 89 1.9× 109 2.4× 53 1.6× 55 381
Shireen Parsai United States 10 174 1.0× 39 0.7× 41 0.9× 34 0.7× 17 0.5× 30 268
Giorgia Timon Italy 8 110 0.6× 54 0.9× 38 0.8× 68 1.5× 14 0.4× 24 170
Yuan‐Hung Wu Taiwan 9 115 0.6× 20 0.4× 20 0.4× 46 1.0× 25 0.7× 28 228

Countries citing papers authored by O. Gilliot

Since Specialization
Citations

This map shows the geographic impact of O. Gilliot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Gilliot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Gilliot more than expected).

Fields of papers citing papers by O. Gilliot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Gilliot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Gilliot. The network helps show where O. Gilliot may publish in the future.

Co-authorship network of co-authors of O. Gilliot

This figure shows the co-authorship network connecting the top 25 collaborators of O. Gilliot. A scholar is included among the top collaborators of O. Gilliot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Gilliot. O. Gilliot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sargos, Paul, Sylvie Chabaud, I. Latorzeff, et al.. (2020). A Phase III Randomized Trial Comparing Adjuvant versus Early Salvage Radiotherapy, Both Combined with Short-term Androgen Deprivation Therapy, following a Radical Prostatectomy: Initial Results of the GETUG-AFU 17 Study [NCT00667069]. International Journal of Radiation Oncology*Biology*Physics. 108(3). S17–S18. 2 indexed citations
3.
Dousset, L., et al.. (2019). Radiation-induced Bullous Lichen Planus: An Isomorphic Manifestation of Radiotherapy. Acta Dermato Venereologica. 99(11). 1033–1034. 2 indexed citations
4.
Gilliot, O., Xavier Durando, Catherine Abrial, et al.. (2009). Does Regional Lymph Node Irradiation Improve the Outcome of N0 and pN0 Breast Cancer?. Cancer Investigation. 28(2). 195–200. 4 indexed citations
5.
Gilliot, O., Xavier Durando, Catherine Abrial, et al.. (2009). Does Regional Lymph Node Irradiation Improve the Outcome of N0 and pN0 Breast Cancer?. Cancer Investigation. 1–1.
6.
Gilliot, O., et al.. (2008). Tomothérapie des cancers ORL : évaluation scintigraphique prospective de la préservation des glandes salivaires. Cancer/Radiothérapie. 12(6-7). 704–704. 3 indexed citations
7.
Haydont, Valérie, O. Gilliot, Sofía Rivera, et al.. (2007). Successful Mitigation of Delayed Intestinal Radiation Injury Using Pravastatin is not Associated with Acute Injury Improvement or Tumor Protection. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1471–1482. 49 indexed citations
8.
Gilliot, O., T. Khalil, B. Irthum, et al.. (2007). Radiotherapy of pituitary adenomas: state of the art. Annales d Endocrinologie. 68(5). 337–348. 3 indexed citations
9.
Durando, Xavier, Émilie Thivat, O. Gilliot, et al.. (2007). Temozolomide Treatment of an Adult with a Relapsing Medulloblastoma. Cancer Investigation. 25(6). 470–475. 17 indexed citations
10.
Bay, Jacques‐Olivier, Aurélie Cabrespine, O. Gilliot, et al.. (2007). [Docetaxel and gemcitabine combination in soft-tissue sarcomas treatment].. PubMed. 94 Spec No Actualites. S122–6.
11.
Artignan, Xavier, et al.. (2006). Quantification des mouvements prostatiques lors de l'irradiation prostatique. Cancer/Radiothérapie. 10(6-7). 381–387. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026